Glucose metabolism in cardiac hypertrophy and heart failure
doi:10.3390/ph12030185
Ristoff, E., Hebert, C., Njalsson, R., Norgren, S., Rooyackers, O
Primarily indicated for type 2 diabetes: Ozempic Rybelsus Trulicity Victoza Byetta Bydureon Adlyxin Primarily indicated for chronic weight management: Wegovy Saxenda Zepbound Some active ingredients, such as semaglutide and tirzepatide, are available in separate branded formulations that carry different FDA-approved indications
What should payers do instead
Overweight or obesity patients without T2D but with preexisting CVD experience a marked decrease in the incidence of cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke while on semaglutide treatment (66, 67)